Yuri Maricich - 03 Dec 2021 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
07 Dec 2021, 16:23:03 UTC
Next filing
18 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PEARQ Class A Common Stock Award +73,620 73,620 03 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award +73,620 73,620 03 Dec 2021 Common Stock 73,620 $0.0200 Direct F2, F3
transaction PEARQ Stock Option (Right to Buy) Award +44,172 44,172 03 Dec 2021 Common Stock 44,172 $0.6800 Direct F2, F4
transaction PEARQ Stock Option (Right to Buy) Award +176,689 176,689 03 Dec 2021 Common Stock 176,689 $0.1400 Direct F2, F5
transaction PEARQ Stock Option (Right to Buy) Award +103,068 103,068 03 Dec 2021 Common Stock 103,068 $0.7200 Direct F2, F6
transaction PEARQ Stock Option (Right to Buy) Award +88,344 88,344 03 Dec 2021 Common Stock 88,344 $1.08 Direct F7, F8
transaction PEARQ Stock Option (Right to Buy) Award +103,068 103,068 03 Dec 2021 Common Stock 103,068 $1.09 Direct F9, F10
transaction PEARQ Stock Option (Right to Buy) Award +220,862 220,862 03 Dec 2021 Common Stock 220,862 $1.29 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for 50,000 shares of common stock of Private Pear previously held by Mr. Maricich.
F2 100% of the shares subject to this option are fully vested and exercisable.
F3 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 50,000 shares of common stock of Private Pear for $0.02 per share.
F4 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.00 per share.
F5 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 120,000 shares of common stock of Private Pear for $0.20 per share.
F6 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.05 per share.
F7 25% of the shares underlying the option vested or shall vest on March 14, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F8 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 60,000 shares of common stock of Private Pear for $1.58 per share.
F9 25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F10 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 70,000 shares of common stock of Private Pear for $1.60 per share.
F11 25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
F12 Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 150,000 shares of common stock of Private Pear for $1.89 per share.